tirzepatide risk of cancer BREAKING NEWS 🚨 A new study from the University Michigan found that SHRINKS BREAST TUMORS IN MICE. For women 40–55, this matters. Weight gain and breast cancer both Tirzepatide and Thyroid Cancer: UK

Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial

Most Commonly Reported Side Effects Nausea Diarrhea Vomiting Constipation Decreased appetite Injection site reactions Serious but less common risks include pancreatitis, gallbladder disease, and a possible risk of thyroid C-cell tumors based on animal studies

Notably, no cases of clinically significant hypoglycemia, medullary thyroid cancer, or C-cell hyperplasia were reported in published trial data

That was the thing that was most interesting to me, because it was, like, side effects that you get with anti hypertensive treatment drugs, which was very interesting